Consensus Obio Technology (Shanghai) Corp., Ltd.

Equities

688238

CNE1000059N9

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
5.05 ^CNY	+2.64%		-10.62%	-43.83%

05-30	OBiO Technology Officially Launches the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases	CI
05-16	Obio Technology's Shareholders to Offload Up to 1.5% Stake	MT

Evolution of the average Target Price on Obio Technology (Shanghai) Corp., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

a58ff7aeafa1a1dedf21668cdd.ucRNsqNZvJSFfGaNdliOgpv_kd5F7aHRm7c4FQrq15s.z_cI0dsP48T3EAC4FTu_w9m2_Kg8mP6O7v1ZemO_nd7MsRfI9TOI4ccbAQ~43dd289eabd407428369155917299c0e

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.05 CNY

Average target price

8.2 CNY

Spread / Average Target

+62.38%

High Price Target

8.2 CNY

Spread / Highest target

+62.38%

Low Price Target

8.2 CNY

Spread / Lowest Target

+62.38%

Consensus detail

Consensus revision (last 18 months)

Ratings for Obio Technology (Shanghai) Corp., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar